Autologous adipose injection for shoulder pain in wheelchair users with spinal cord injury

California governor says mask mandate to end after June 15
12 May 2021
World could have prevented COVID catastrophe: pandemic panel
12 May 2021

Autologous adipose injection for shoulder pain in wheelchair users with spinal cord injury

A team of specialists in regenerative rehabilitation conducted a successful pilot study investigating micro-fragmented adipose tissue (MFAT) injection for rotator cuff disease in wheelchair users with spinal cord injury. They demonstrated that MFAT injection has lasting pain-relief effects. The article, “A pilot study to evaluate micro-fragmented adipose tissue injection under ultrasound guidance for the treatment of refractory rotator cuff disease in wheelchair users with spinal cord injury,” was published ahead of print on April 8, 2021, by the Journal of Spinal Cord Medicine.

Comments are closed.